Jonathan Sporn holds a BS from Duke University and an MD from the University of Miami. He has held leadership roles including Chief of Psychiatry in the Boston area, researcher at Mass General Hospital and the NIH, and clinical positions at Johnson & Johnson and Pfizer in neuroscience and psychiatry. He previously founded Perception Neuroscience, which exited, and is currently an Assistant Professor of Psychiatry and Experimental Therapeutics at Columbia University while founding Gilgamesh Pharmaceuticals.
Intro paths
Jonathan went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Gilgamesh Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
In turn, Jonathan can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 10
Co-founders
